SOCS1 and B-cell non-Hodgkin lymphoma: SOCS1 represents a key inhibitor of JAK-STAT signaling and inactivating SOCS1 mutations have been reported in subsets of B-cell lymphomas including EBV-associated DLBCLs in HIV-infected individuals [47, 48].